Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
作者： Paul E. Goss , James N. Ingle , Kathleen I. Pritchard , Nicholas J. Robert , Hyman Muss
关键词:
摘要: Canadian Cancer Society Research Institute [021039, 015469]; National [CA180888, CA189953, CA180828, CA13612, CA37981, CA077202, CA180863, CA67753, CA189805, CA16116, CA180802]; Trials Group [CA077202, CA180863]; ECOG-ACRIN [CA180820, CA21115]; Novartis Pharmaceuticals; Avon Foundation; AstraZeneca; Pfizer; Roche; Amgen; Novartis; Glaxo-SmithKline; Eisai; Genomic Health; NanoString; Genentech; BioMarin
elsevier.com
openrepository.com
sci-hub.se 参考文章(15)
John E. Ware, SF-36 health survey: Manual and interpretation guide ,(2003)
R. G. Gray, D. W. Rea, K. Handley, A. Marshall, M. G. Pritchard, P. Perry, H. M. Earl, C. J. Poole, A. Salman, M. Lee, , aTTom (adjuvant Tamoxifen—To offer more?): Randomized trial of 10 versus 5 years of adjuvant tamoxifen among 6,934 women with estrogen receptor-positive (ER+) or ER untested breast cancer—Preliminary results Journal of Clinical Oncology. ,vol. 26, pp. 513- 513 ,(2008) , 10.1200/JCO.2008.26.15_SUPPL.513
Mike J Clarke, WITHDRAWN: Tamoxifen for early breast cancer. Cochrane Database of Systematic Reviews. ,(2008) , 10.1002/14651858.CD000486.PUB2
Geoffrey R. Norman, Jeff A. Sloan, Kathleen W. Wyrwich, Interpretation of changes in health-related quality of life the remarkable universality of half a standard deviation Medical Care. ,vol. 41, pp. 582- 592 ,(2003) , 10.1097/01.MLR.0000062554.74615.4C
Ann H. Partridge, Philip S. Wang, Eric P. Winer, Jerry Avorn, Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer Journal of Clinical Oncology. ,vol. 21, pp. 602- 606 ,(2003) , 10.1200/JCO.2003.07.071
Kathrin Strasser-Weippl, Tanja Badovinac-Crnjevic, Lei Fan, Paul E. Goss, Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer The Breast. ,vol. 22, pp. S171- S175 ,(2013) , 10.1016/J.BREAST.2013.07.033
John E. Ware, Cathy Donald Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. ,vol. 30, pp. 473- 483 ,(1992) , 10.1097/00005650-199206000-00002
Edith A. Perez, Robert G. Josse, Kathleen I. Pritchard, James N. Ingle, Silvana Martino, Brian P. Findlay, Tamara N. Shenkier, Richard G. Tozer, Michael J. Palmer, Lois E. Shepherd, Shifang Liu, Dongsheng Tu, Paul E. Goss, Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17 Journal of Clinical Oncology. ,vol. 24, pp. 3629- 3635 ,(2006) , 10.1200/JCO.2005.05.4882
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, Patrick Therasse, Michael J. Palmer, Joseph L. Pater, A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer New England Journal of Medicine. ,vol. 349, pp. 1793- 1802 ,(2003) , 10.1056/NEJMOA032312
John R. Hilditch, Jacqueline Lewis, Alice Peter, Barbara van Maris, Alan Ross, Edmée Franssen, Gordon H. Guyatt, Peter G. Norton, Earl Dunn, A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas. ,vol. 24, pp. 161- 175 ,(1996) , 10.1016/S0378-5122(96)82006-8